Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 78.00
+0.40 (0.52%)
Mar 9, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 382.14 million as of March 9, 2026. Its market cap has decreased by -14.54% in one year.
Market Cap
382.14M
Enterprise Value
358.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
78.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 382.14M, an increase of 232.19%. That is a compound annual growth rate of 31.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 382.14M | - |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIOTON | 355.48M |
| Captor Therapeutics Spolka Akcyjna | 483.21M |
| Synthaverse | 254.77M |
| Ryvu Therapeutics | 590.72M |
| Molecure | 147.93M |
| Mabion | 130.11M |
| Poltreg | 115.19M |
| NanoGroup | 82.89M |